Associated Papers
Clinicopathologic Features and the Spectrum of Myelokathexis in Warts, Hypogammaglobulinemia, Infections, Myelokathexis Syndrome.
Li J et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2025
A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
McDermott DH et al.
The Journal of Clinical Investigation, 2023
37561579 (PubMed )
Supplement: jci-133-164918-s097.pdf
Unraveling the genetics of transformed splenic marginal zone lymphoma.
Grau M et al.
Blood Advances, 2023
36995085 (PubMed )
Supplement: BLOODA_ADV-2022-009415-mmc1.xlsx › ST7
Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
Laberko A et al.
Journal of Clinical Immunology, 2022
Case Report: A Novel CXCR4 Mutation in a Chinese Child With Kawasaki Disease Causing WHIM Syndrome.
Ma X et al.
Frontiers in Immunology, 2022
Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom's Macroglobulinemia.
Milanesi S et al.
International Journal of Molecular Sciences, 2020
High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations.
Pillonel V et al.
Leukemia, 2018
29556019 (PubMed )
Supplement: 41375_2018_82_MOESM10_ESM.xlsx › .
How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.
Badolato R et al.
Blood, 2017
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.
Beaussant Cohen S et al.
Orphanet Journal of Rare Diseases, 2012
Select a paper to view details